We're secretly winning the war on cancer
is a senior editorial director at Vox overseeing the climate teams and the Unexplainable and The Gray Area podcasts. He is also the editor of Vox's Future Perfect section and writes the Good News newsletter. He worked at Time magazine for 15 years as a foreign correspondent in Asia, a climate writer, and an international editor, and he wrote a book on existential risk.
Thousands of people gather on the National Mall in Washington, DC, on September 26, 1998, to demand that the cause, the care, and the cure of cancer be made top research and healthcare priorities in the US. Paul J. Richards/AFP via Getty Images
On November 4, 2003, a doctor gave Jon Gluck some of the worst news imaginable: He had cancer — one that later tests would reveal as multiple myeloma, a severe blood and bone marrow cancer.
Jon was told he might have as little as 18 months to live. He was 38, a thriving magazine editor in New York with a 7-month-old daughter whose third birthday, he suddenly realized, he might never see.
'The moment after I was told I had cancer, I just said 'no, no, no,'' Jon told me in an interview just last week. 'This cannot be true.'
Living in remission
The fact that Jon is still here, talking to me in 2025, tells you that things didn't go the way the medical data would have predicted on that November morning. He has lived with his cancer, through waves of remission and recurrence, for more than 20 years, an experience he chronicles with grace and wit in his new book An Exercise in Uncertainty. That 7-month-old daughter is now in college.
You could say Jon has beaten the odds, and he's well aware that chance played some role in his survival. ('Did you know that 'Glück' is German for 'luck'?' he writes in the book, noting his good fortune that a random spill on the ice is what sent him to the doctor in the first place, enabling them to catch his cancer early.) Cancer is still a terrible health threat, one that is responsible for 1 in 6 deaths around the world, killing nearly 10 million people a year globally and over 600,000 people a year in the US.
But Jon's story and his survival demonstrate something that is too often missed: We've turned the tide in the war against cancer.
The age-adjusted death rate in the US for cancer has declined by about a third since 1991, meaning people of a given age have about a third lower risk of dying from cancer than people of the same age more than three decades ago. That adds up to over 4 million fewer cancer deaths over that time period. Thanks to breakthroughs in treatments like autologous stem-cell harvesting and CAR-T therapy — breakthroughs Jon himself benefited from, often just in time — cancer isn't the death sentence it once was.
Our World in Data
Getting better all the time
There's no doubt that just as the rise of smoking in the 20th century led to a major increase in cancer deaths, the equally sharp decline of tobacco use eventually led to a delayed decrease. Smoking is one of the most potent carcinogens in the world, and at the peak in the early 1960s, around 12 cigarettes were being sold per adult per day in the US. Take away the cigarettes and — after a delay of a couple of decades — lung cancer deaths drop in turn along with other non-cancer smoking-related deaths.
But as Saloni Dattani wrote in a great piece earlier this year, even before the decline of smoking, death rates from non-lung cancers in the stomach and colon had begun to fall. Just as notably, death rates for childhood cancers — which for obvious reasons are not connected to smoking and tend to be caused by genetic mutations — have fallen significantly as well, declining sixfold since 1950. In the 1960s, for example, only around 10 percent of children diagnosed with acute lymphoblastic leukemia survived more than five years. Today it's more than 90 percent. And the five-year survival rate for all cancers has risen from 49 percent in the mid-1970s to 69 percent in 2019.
We've made strikes against the toughest of cancers, like Jon's multiple myeloma. Around when Jon was diagnosed, the five-year survival rate was just 34 percent. Today it's as high as 62 percent, and more and more people like Jon are living for decades. 'There has been a revolution in cancer survival,' Jon told me. 'Some illnesses now have far more successful therapies than others, but the gains are real.'
Three cancer revolutions
The dramatic bend in the curve of cancer deaths didn't happen by accident — it's the compound interest of three revolutions.
While anti-smoking policy has been the single biggest lifesaver, other interventions have helped reduce people's cancer risk. One of the biggest successes is the HPV vaccine. A study last year found that death rates of cervical cancer — which can be caused by HPV infections — in US women ages 20–39 had dropped 62 percent from 2012 to 2021, thanks largely to the spread of the vaccine. Other cancers have been linked to infections, and there is strong research indicating that vaccination can have positive effects on reducing cancer incidence.
The next revolution is better and earlier screening. It's generally true that the earlier cancer is caught, the better the chances of survival, as Jon's own story shows. According to one study, incidences of late-stage colorectal cancer in Americans over 50 declined by a third between 2000 and 2010 in large part because rates of colonoscopies almost tripled in that same time period. And newer screening methods, often employing AI or using blood-based tests, could make preliminary screening simpler, less invasive and therefore more readily available. If 20th-century screening was about finding physical evidence of something wrong — the lump in the breast — 21st-century screening aims to find cancer before symptoms even arise.
Most exciting of all are frontier developments in treating cancer, much of which can be tracked through Jon's own experience. From drugs like lenalidomide and bortezomib in the 2000s, which helped double median myeloma survival, to the spread of monoclonal antibodies, real breakthroughs in treatments have meaningfully extended people's lives — not just by months, but years.
Perhaps the most promising development is CAR-T therapy, a form of immunotherapy. Rather than attempting to kill the cancer directly, immunotherapies turn a patient's own T-cells into guided missiles. In a recent study of 97 patients with multiple myeloma, many of whom were facing hospice care, a third of those who received CAR-T therapy had no detectable cancer five years later. It was the kind of result that doctors rarely see.
'CAR-T is mind-blowing — very science-fiction futuristic,' Jon told me. He underwent his own course of treatment with it in mid-2023 and writes that the experience, which put his cancer into a remission he's still in, left him feeling 'physically and metaphysically new.'
A welcome uncertainty
While there are still more battles to be won in the war on cancer, and there are certain areas — like the rising rates of gastrointestinal cancers among younger people — where the story isn't getting better, the future of cancer treatment is improving. For cancer patients like Jon, that can mean a new challenge — enduring the essential uncertainty that comes with living under a disease that's controllable but which could always come back.
But it sure beats the alternative.
'I've come to trust so completely in my doctors and in these new developments,' he said. 'I try to remain cautiously optimistic that my future will be much like the last 20 years.' And that's more than he or anyone else could have hoped for nearly 22 years ago.
A version of this story originally appeared in the Good News newsletter. Sign up here!
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
3 days ago
- New York Post
Lock into longevity at Lanserhof Sylt, the iconic German wellness retreat
Before there was Michael Pollan and his 'intentional eating' MasterClass, before there was 'intermittent fasting' and the Wim Hof Method, there was Franz Xaver Mayr, the early-20th-century Austrian physician. His revolutionary Mayr Method was grounded in the belief that the secret to health and beauty starts in the gut. His cult-like following led to the opening of his own clinic, and, eventually, to Lanserhof, a wellness and longevity retreat at whose fourth outpost I presently find myself. Somehow by my own choosing. Arriving to the remote German island of Sylt, considered by some to be the Teutonic version of the Hamptons, if the Hamptons had fewer beach clubs and more colonics, takes some effort. Which is, of course, the point. Guests must take a four-hour train ride across the Hindenburg causeway from Hamburg to arrive at the town of List, where, among the waves and heather, Lanserhof Sylt seems to levitate above the dunes. The whisper-quiet, thatch-roofed structure (the largest of its kind in Europe) designed by architect Christoph Ingenhoven offers no check-in desk, no custom scent, no chipper guide to assuage your fears of eating only 750 calories per day. This, too, is the point. At Lanserhof, escaping the pressures of the real world, tuning your senses to your body and your environment, is also part of the treatment. 5 Lanserhof is tucked on the remote German island of Sylt. Courtesy of Lanserhof Sylt I arrived from New York depleted — existentially tired in a way that no spa day or vacation could possibly resolve. Time had no meaning, I was exhausted, unfocused, unable to sleep. Relentless deadlines, continental moves, the news cycle… it was enough to throw me into a midlife spiral that, I decided, only a week away, alone, could heal. So, no, I hadn't booked myself into Lanserhof to lose those few winter pounds (as one gentleman guest revealed) or to keep a chronic illness in check (as a sufferer of 'leaky gut syndrome' told me). I was here to sleep without meds and to enlist in Lanserhof's Longevity Program, one that would sustain my body on this mortal coil for as long as possible, in peak(ish) fitness. In other words, I was here for what Lanserhof promises at its core: a scientifically rigorous, medically monitored reset. 5 A weeklong visit at the retreat begins with a series of health tests to gauge visitors' wellness needs. Courtesy of Lanserhof Sylt The clinic's approach, the Lanserhof Cure, is rooted in what practitioners call 'Medicine 3.0' — an evolution of preventive medicine that sees aging itself as a treatable condition. That translates to personalized diagnostics, one-on-one consultations and daily interventions calibrated to your own genes, cells and metabolism. It also means that a weeklong stay begins with a series of tests (blood panels, body composition scans, a fragility score assessment) and meetings with medical directors Jan Strizke and Christina Haeggberg, who walked me through my data with clinical candor. Turns out, my vitamin D was low. My calcium, borderline. My posture? Protective. My hips and knees and shoulder were subtly rotating to shield an overworked psoas muscle — a compensation I would never have known about if not for the wizarding osteopath who, in a single session, released my lower back and relieved a steady pain I'd endured for two decades. If the diagnostics and physical therapies were hardcore, the protocols were equally so. I received an infusion of something yellow (Vitamin D?) during two CellGym sessions, designed to mimic altitude training and increase my mitochondrial health. I braved five stints in a cryo chamber chilled to -110°C, my breath slowing as the technician danced along with me outside the glass door to three-minute classics. ('Time Warp' seems to know no language barrier, and certainly speeds along the endless 180 seconds, as its title suggests.) My massage therapist insisted I was too tight for a conventional massage. 'You need abyanga,' she said. 'Something deeper.' No kidding. 5 Regimens at Lanserhof are designed to recalibrate your body, from posture to digestion. Courtesy of Lanserhof Sylt Deeper was a theme. At Lanserhof Sylt, the body is treated as a system of interdependent parts, not a series of symptoms to manage. You have to get to the cellular level to manifest change. Nutrition was no exception. I met with the clinic's quietly formidable dietitian, who analyzed not just what I ingest, but how. Her verdict: I wasn't eating enough, and when I did, it was inconsistent. Worse, I wasn't chewing properly — an offense here of almost spiritual magnitude. Dr. Mayr believed that each bite of food requires 30 to 40 chews, and, rather shamefully, Dr. Haeggberg had to teach me how to chew properly. 'Digestion begins in the mouth,' she insisted. Other beads of wisdom: No talking while eating. No water for thirty minutes on either side of a meal. Nothing but tea after supper, which should end by 7:30 pm. To ensure my colon was cleared by week's end, every day began with a swig of Epsom salts. Thank goodness I sat alone, not complaining to my table neighbors at lunch. Instead, each meal forced me to reflect on my choices, on the wind, on my relationship to food and people. Sparse but elegant, meals consisted of a dainty serving of coconut yogurt, a small plate of spelt pasta with vegan Bolognese, smoothies presented in bowls with tiny spoons. By day four, my headache and my hunger faded. My appetite recalibrated. I began to taste food again — not just consume it. It's amazing what 40 chews can do. 5 Guests work with experts to regulate their sleep schedules. Courtesy of Lanserhof Sylt Not everything was about food or fascia. I spent quality time with Heide, a therapist who gently suggested I schedule a daily 'worry window' to contain my anxiety around falling asleep. (Good sleep hygiene is critical to longevity.) Her sleep retraining strategy required me to lie in bed and observe my breath for 30 minutes, then get up and read in another room. It felt punitive at first, leaving my nerves threadbare and my body tired. But by Wednesday, my brain had learned how to self-soothe, how to surrender. Months later, I remain Ambien-free. Other than running on treadmills strapped to some tubes or sitting in on lectures about gut health or group yoga sessions, there's little to do at Lanserhof Sylt. At least, that was what I entered this journey thinking. Once my sleep and my hunger were regulated, I made myself available to nature. One day was marked by a lengthy bike ride into town. Another included a 10-mile run on the boardwalk, resisting the urge to buy a beer at a café. I read three books by the fireplace. (No electronics allowed!) One night, I sipped kombucha and watched the sky blush pink and gold as the sun melted into the sea through the glass wall, a scene so quietly introspective, it resided a world apart from offspring and deadlines. Conversations with my fellow guests — in the pool, on a morning walk, by that fireplace — were deeply personal and earnest. It was easy to forget that most of us had arrived here feeling broken, hoping 'The Lanserhof Cure' would cure us all. 5 Forcing you away from electronics and deadlines, retreat guests rediscover nature and mindfulness through holistic practices. Courtesy of Lanserhof Sylt On my final morning, confident in my newfound 'wellth,' I layered my coat over my swimsuit, stripped down, and marched into the North Sea. The sting of the salty 2°C water was instant. My extremities went numb, my core felt hot. For a full minute I fought the urge to run. Or to cry. And then, without fanfare, the pain passed. I emerged euphoric, unreasonably proud of my silly, self-imposed achievement. I can do hard things! Even sleep without meds. Even chew a bite of spelt bread 40 times. Maybe I can even live in health forever. 8-night Lanserhof Classic Plus from €4,046, not including accommodation. Rooms from €649 per night; Lanserhof
Newsweek
4 days ago
- Newsweek
Woman Sets Out on 'Mental Health Walk,' But Dog Had Other Plans
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The internet couldn't stop laughing at a woman's attempt to clear her mind during a refreshing walk outside, being interrupted by her dog. Chamee Barkman, who is known on TikTok as @chameebarkmanx, needed to get outside for some fresh air and a "mental health walk." But as a dog owner, it only made sense to attempt to hit two birds with one stone and take her German shepherd with her. Getting in your daily steps is known to boost your mood, as it increases blood flow to both the brain and body. It helps support an active and healthy lifestyle. Additionally, walking can improve sleep, reduce stress, increase energy and mental alertness, aid in weight loss, lower cholesterol, and enhance heart health, according to WebMD. And while this was the intent for Barkman's walk, as well as to get her canine out of the house, her dog decided he wasn't interested. He needed the walk to release his energy. In her June 9 video, she filmed herself walking and holding the dog's leash. All seemed calm until she flipped the camera around to show what she was dealing with: her dog sprinting around her in circles. He hopped through the tall grass, taking a quick breather and looking at Barkman before running past her for rounds two, three and four. It wasn't what Barkman imagined for a mental health walk. In fact, she wrote on the clip that her dog was "making it worse." Newsweek reached out to @chameebarkmanx via TikTok for comment. Screenshots from a June 9 TikTok video of a woman trying to go on a "mental health walk" but her dog running around and making it a bit worse. Screenshots from a June 9 TikTok video of a woman trying to go on a "mental health walk" but her dog running around and making it a bit worse. @chameebarkmanx/TikTok Viewer Reactions The dog's total disregard for a calm walk left people in stitches, bringing in over 3.3 million views and 438,900 likes on TikTok as of Tuesday. "I'm laughing at how horrible it feels to be in this situation because it's your last straw and they're just vibing," commented a viewer. "And then you can't go on a walk by yourself because you'll feel guilty that your dog should be getting a walk too," a second viewer commented. Another commenter pointed out: "The dog even looked back like, 'You good?' and then carried on." Others defended the dog's behavior: "To be fair, that's his mental health walk too, and he seems to be enjoying it." Do you have funny and adorable videos or pictures of your pet you want to share? Send them to life@ with some details about your best friend, and they could appear in our Pet of the Week lineup.
Yahoo
4 days ago
- Yahoo
Novo Nordisk Reclaims Top Spot in Europe by Market Value
Novo Nordisk A/S (NYSE:NVO) is among the best bear market stocks to buy according to analysts. Novo Nordisk A/S (NYSE:NVO) has reclaimed its crown as Europe's most valuable publicly traded company, surpassing German software giant SAP SE (ETR:SAPG). With a market capitalization of $355.904 billion, the giant's stock surged by nearly 10% in the last five days. Two major developments have taken place in recent days. Firstly, Novo Nordisk A/S (NYSE:NVO) has revealed its plan to advance its amycretin treatments into Phase 3 clinical trials for weight management. By the first quarter of 2026, the company expects to launch a Phase 3 development program for amycretin aimed at overweight or obese adults. An elderly couple receiving insulin from a pharmacist, representing healthcare company's successful pharmaceutical products. Secondly, the Financial Times reported that activist hedge fund Parvus Asset Management has purchased shares of the company, which further boosted investor confidence. Moves like these signal that Novo Nordisk A/S (NYSE:NVO) is truly a leader in the market. Novo Nordisk A/S (NYSE:NVO) is a Denmark-based company that engages in the research and development, manufacture, and commercialization of pharmaceutical products. Founded in 1923, it has two main segments: Diabetes and Obesity Care, and Rare Diseases. While we acknowledge the potential of NVO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
